Aarkstore - Opioids Market Overview to 2023

1. Aarkstore - Opioids Market Overview to 2023 - Opioidsin Emerging Markets To buy this Report Visit http://www.aarkstore.com

2. Discounted Market Research Reports available on Aarkstore.com Offer valid till 28th February, 2015 • For more inquiries, contact at +91 9987295242 / 022-27564953 • Email: enquiry@aarkstore.com To buy this Report Visit http://www.aarkstore.com

3. Summary The report Opioids in Emerging Markets provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential. Emphasis on restricting access to controlled drugs is much higher in emerging markets than in developed nations, resulting in a level of consumption that is too low to meet pain-control requirements even in cases of terminal illness. There is a high level of unmet need for pain control in both cancer and HIV/AIDS, and serious concerns have been raised regarding inadequate pain management in the emerging markets. However, this is expected to change in the near future as regulatory authorities attempt to remedy the situation. Indeed, several new developments promise a better outlook for future access. Although India currently has a minor share of the market, it is expected to post a high growth rate (21.3% by 2023) due to improved access to opioid analgesics. Similarly, consumption in Brazil and Argentina is also expected to increase due to recent changes to their palliative care policies. Although the opioids market in emerging countries is small, it is expected to grow at a faster pace in forecast period than in some developed countries.

4. Scope ""Opioids in Emerging Markets covers"" the major emerging markets of Argentina, Brazil, China, India, Mexico, Russia, and South Africa, and includes -  - Discussion of the key challenges that restrict opioid use in pain management - Analysis of the inadequate use of opioids in pain control and the associated unmet need - Discussion of the key changes in the regulatory and legal landscape that affect opioids, prescription barriers, palliative care, and harm-reduction activities - Analysis of recent developments in emerging markets and their expected impact on opioid accessibility and usage - Country snapshots, which include key regulations, consumption, market revenues and forecasts, and key drivers and barriers in India, Brazil and South Africa - Snapshot of consumption trends along with market revenues and forecasts in Argentina and China

5. Key Reasons to Purchase  - Understand the key constraints in emerging markets that limit the use of opioids in pain management - Understand recent changes in the regulatory environment and gauge their impact on opioid usage - Gain perspective on the unmet need in the opioids market - Understand the market size and growth potential in emerging markets and identify high-potential countries for opioid products Browse Complete Report – http://www.aarkstore.com/pharmaceuticals-healthcare/81547/opioids-market-overview-opioids-in-emerging-markets

6. Table of Contents • Executive summary • Opioids in pain management  • Opioids in emerging markets: an overview •  Low utilization of opioids • Changing regulatory landscape  •  Key challenges and barriers in emerging markets •  Factors affecting opioidusage •  Highly restricted environment • Criminalization of drug use •  Lack of palliative care  • Lack of harm-reduction strategies • Opioidconsumption in emerging markets • Country snapshots (Brazil, India and South Africa)

7. Related Market Research Report • LipodystrophyGlobal Clinical Trials Review, H1, 2014 • Hyperinsulinemia Global Clinical Trials Review, H1, 2014 • Hyperbilirubinemia Global Clinical Trials Review, H1, 2014 • Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 • Familial Chylomicronemia (Type I Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2014 • Generic Drugs Market in Japan 2015-2019 • Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Metastatic Brain Tumor-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Lupus Erythematosus-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 • Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

8. About Aarkstore Enterprise • Aarkstore Enterprise provides Industry and Market Analysis and Research Report with expertise and technology knowledge on business improvement and market acquisition. • Aarkstore achieved its debut pad in the year 2008 to explore, work on assignments and cater worldwide clients and business giants with business research on trends, markets and technologies. The latest set of applications guarantees active analysis and Market Research understanding for budding enterpriser and consultants to relate industry ground research.

9. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news